Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Normal Upper Extremity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05952128
What this trial is testing

Phase Ib/II Study of Fluzoparib in Combination With Dalpiciclib in Patients With Locally Advanced or Metastatic Sarcoma

Who this might be right for
Sarcoma
Sun Yat-sen University 50
Testing effectiveness (Phase 2)Study completedNCT01412892
What this trial is testing

Use of RAD001 as Monotherapy in the Treatment of Neurofibromatosis 1 Related Internal Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis Type 1Plexiform NeurofibromaNeurofibromatoses
Assistance Publique - Hôpitaux de Paris 30
Post-approval studies (Phase 4)Study completedNCT01898585
What this trial is testing

An Open-Label Study of Zelboraf (Vemurafenib) in Patients With Braf V600 Mutation Positive Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 60
Early research (Phase 1)Study completedNCT01111097
What this trial is testing

Study of the Safety and Efficacy of Dichloroacetate (DCA) in Glioblastoma and Other Recurrent Brain Tumors

Who this might be right for
Brain TumorGlioblastoma
University of Florida 15
Testing effectiveness (Phase 2)Study completedNCT02481050
What this trial is testing

Study to Evaluate the Efficacy and Safety of Eribulin Mesylate Administered Biweekly (Q2W) for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Eisai Inc. 58
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07650838
What this trial is testing

OVV-01 Injection Combined With AK112 Injection for the Treatment of Patients With Advanced Soft Tissue Sarcoma (STS)

Who this might be right for
Soft Tissue Sarcoma (STS)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40
Large-scale testing (Phase 3)Looking for participantsNCT06641089
What this trial is testing

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response

Who this might be right for
Arthritis, Psoriatic
MoonLake Immunotherapeutics AG 600
Testing effectiveness (Phase 2)Looking for participantsNCT06933394
What this trial is testing

Arsenic Trioxide With MAPK Inhibitors and Chemotherapy for Stage 4/M Neuroblastoma

Who this might be right for
Neuroblastoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 92
Testing effectiveness (Phase 2)UnknownNCT02848794
What this trial is testing

Apatinib and Irinotecan in Treating Patients With Recurrent High-grade Glioma

Who this might be right for
High-grade Glioma
The First People's Hospital of Lianyungang 40
Not applicableStudy completedNCT06319586
What this trial is testing

The Radial Forearm Flap In Reconstruction Of Upper Limb Injuries

Who this might be right for
for Upper Limb Soft Tissue Coverage
Sohag University 20
Large-scale testing (Phase 3)Looking for participantsNCT07221851
What this trial is testing

Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders

Who this might be right for
Turner SyndromeShort Stature Homeobox Gene MutationIdiopathic Short Stature+1 more
Ascendis Pharma A/S 186
Not applicableStudy completedNCT05254470
What this trial is testing

Real-World Experience of Patients Treated for Musculoskeletal Injuries With SAM in Routine Care

Who this might be right for
Musculoskeletal InjuryPain, ChronicPain, Acute+6 more
ZetrOZ, Inc. 135
Not applicableUnknownNCT03978754
What this trial is testing

Assessment of Breast Cancer-Related Arm Lymphedema

Who this might be right for
Breast Cancer
Peking University People's Hospital 1,600
Testing effectiveness (Phase 2)UnknownNCT05823623
What this trial is testing

Inetetamab Combined With Pyrotinib Plus Oral Vinorelbine for the Treatment of HER2-positive Metastatic Breast Cancer

Who this might be right for
Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 30
Not applicableStudy completedNCT05950685
What this trial is testing

Prediction of Long-term Arm Morbidity Following Breast Cancer Surgeries and Treatments

Who this might be right for
Breast Cancer
Ifat Klein 1,602
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06586866
What this trial is testing

JK-1201I in Triple Negative Breast Cancer Patients with Brain Metastases

Who this might be right for
Triple Negative Breast Cancer (TNBC)Brain Metastasases
JenKem Technology Co., Ltd. 25
Testing effectiveness (Phase 2)Study completedNCT06111183
What this trial is testing

Evaluation of AUP12602-C as New Topical Treatment for DFUs (DIAMEND STUDY)

Who this might be right for
Diabetic Foot Ulcer
Aurealis Oy 64
Large-scale testing (Phase 3)Looking for participantsNCT07541079
What this trial is testing

A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)

Who this might be right for
Early Breast Cancer
Genentech, Inc. 300
Early research (Phase 1)Not Yet RecruitingNCT06567080
What this trial is testing

JWCAR201 for the Treatment of Hematology Malignancy and Autoimmune Diseases

Who this might be right for
B-cell TumorsAutoimmune DiseasesLupus Erythematosus, Systemic+1 more
RenJi Hospital 15
Early research (Phase 1)Ended earlyNCT01519323
What this trial is testing

BRIM-P: A Study of Vemurafenib in Pediatric Patients With Stage IIIC or Stage IV Melanoma Harboring BRAFV600 Mutations

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 6
Next Page